Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • merck

    Tag: merck

    You Searched For "merck"
    Currency headwinds quell drug gains in Q4; says Merck KGaA

    Currency headwinds quell drug gains in Q4; says Merck KGaA

    Garima10 March 2019 8:59 AM IST
    FRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Farhat Nasim8 March 2019 9:15 AM IST
    The plaintiffs had accused Merck of not providing sufficient information regarding changes to the Levothyrox.France: A court in the French city of...
    Merck launches cutting edge fertility technologies in India

    Merck launches cutting edge fertility technologies in India

    Farhat Nasim28 Feb 2019 9:05 AM IST
    The introduction of cutting-edge fertility technology complements Merck portfolio and promises to decrease manual labour, increases precision and thus...
    SGLT2 inhibitors can lead to serious genital infection: USFDA warning

    SGLT2 inhibitors can lead to serious genital infection: USFDA warning

    Ruby Khatun Khatun31 Aug 2018 4:50 PM IST
    The SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
    US court upholds dismissal of 200 million dollars Merck verdict against Gilead

    US court upholds dismissal of 200 million dollars Merck verdict against Gilead

    Ruby Khatun Khatun27 April 2018 9:30 AM IST
    A U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
    New GSK shingles vaccine off to strong start in key US market

    New GSK shingles vaccine off to strong start in key US market

    Ruby Khatun Khatun12 April 2018 9:45 AM IST
    LONDON: GlaxoSmithKline's (GSK) new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90...
    Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict

    Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict

    Ruby Khatun Khatun19 Feb 2018 9:45 AM IST
    A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
    Merck

    Merck's consumer health sale at risk as Nestle bows out, says report

    Ruby Khatun Khatun6 Feb 2018 9:45 AM IST
    The sale of Merck KGaA's consumer health unit has been thrown off track after Nestle has pulled out, leaving the race to buy the maker of Seven Seas...
    Pfizer gets USFDA approval for second biosimilar of Remicade

    Pfizer gets USFDA approval for second biosimilar of Remicade

    Ruby Khatun Khatun18 Dec 2017 10:15 AM IST
    The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
    Roche drug cocktail doubles chance of holding lung cancer at bay

    Roche drug cocktail doubles chance of holding lung cancer at bay

    Ruby Khatun Khatun9 Dec 2017 9:45 AM IST
    ZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
    Nestle, Stada prepare rival bids for Merck consumer health: sources

    Nestle, Stada prepare rival bids for Merck consumer health: sources

    Ruby Khatun Khatun6 Dec 2017 9:00 AM IST
    LONDON/FRANKFURT: Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's...
    UK announces pharma investment, aims to boost productivity

    UK announces pharma investment, aims to boost productivity

    Ruby Khatun Khatun1 Dec 2017 9:45 AM IST
    LONDON: Britain has announced a major investment by US drug-maker Merck, as the UK government unveils plans to boost productivity after Brexit.The...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok